Pakistan Production Of Generics Slows To Near Halt Over Price Issues
This article was originally published in PharmAsia News
Executive Summary
Pakistan production of generic drugs has ground nearly to a halt on the Drug Regulatory Authority's long-delayed decision on revising the price controls.